Japan Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026
Japan Pharmaceuticals Market @Summary, Competitive Analysis and Forecast to 2026
SUMMARY
Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Japanese pharmaceuticals market had total revenues of $89.6 billion in 2021, representing a compound annual growth rate (CAGR) of 8% between 2016 and 2021.
- Japan’s aging population is likely to balance the downwards pressure on drug prices, helping to maintain growth in the market over the forecast period.
- The Japanese government believes that by promoting innovations in healthcare to match economic growth, the costs of the aging population will not rise as fast as they have done previously.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Japan pharmaceuticals market by value in 2021?
- What will be the size of the Japan pharmaceuticals market in 2026?
- What factors are affecting the strength of competition in the Japan pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Japan’s pharmaceuticals market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What are the weaknesses of leading players?
7.5. Is there any significant M&A activity on the horizon for next year?
8 COMPANY PROFILES
8.1. Daiichi Sankyo Co Ltd
8.2. Astellas Pharma Inc.
8.3. Mitsubishi Tanabe Pharma Corporation
8.4. Takeda Pharmaceutical Company Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What are the weaknesses of leading players?
7.5. Is there any significant M&A activity on the horizon for next year?
8 COMPANY PROFILES
8.1. Daiichi Sankyo Co Ltd
8.2. Astellas Pharma Inc.
8.3. Mitsubishi Tanabe Pharma Corporation
8.4. Takeda Pharmaceutical Company Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Japan pharmaceuticals market value: $ billion, 2016–21
Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Japan pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: Japan pharmaceuticals market share: % share, by value, 2021
Table 5: Daiichi Sankyo Co Ltd: key facts
Table 6: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 7: Daiichi Sankyo Co Ltd: Key Employees
Table 8: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 9: Astellas Pharma Inc.: key facts
Table 10: Astellas Pharma Inc.: Annual Financial Ratios
Table 11: Astellas Pharma Inc.: Key Employees
Table 12: Mitsubishi Tanabe Pharma Corporation: key facts
Table 13: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 14: Takeda Pharmaceutical Company Limited: key facts
Table 15: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 16: Takeda Pharmaceutical Company Limited: Key Employees
Table 17: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 18: Japan size of population (million), 2017–21
Table 19: Japan gdp (constant 2005 prices, $ billion), 2017–21
Table 20: Japan gdp (current prices, $ billion), 2017–21
Table 21: Japan inflation, 2017–21
Table 22: Japan consumer price index (absolute), 2017–21
Table 23: Japan exchange rate, 2017–21
Table 1: Japan pharmaceuticals market value: $ billion, 2016–21
Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Japan pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: Japan pharmaceuticals market share: % share, by value, 2021
Table 5: Daiichi Sankyo Co Ltd: key facts
Table 6: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 7: Daiichi Sankyo Co Ltd: Key Employees
Table 8: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 9: Astellas Pharma Inc.: key facts
Table 10: Astellas Pharma Inc.: Annual Financial Ratios
Table 11: Astellas Pharma Inc.: Key Employees
Table 12: Mitsubishi Tanabe Pharma Corporation: key facts
Table 13: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 14: Takeda Pharmaceutical Company Limited: key facts
Table 15: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 16: Takeda Pharmaceutical Company Limited: Key Employees
Table 17: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 18: Japan size of population (million), 2017–21
Table 19: Japan gdp (constant 2005 prices, $ billion), 2017–21
Table 20: Japan gdp (current prices, $ billion), 2017–21
Table 21: Japan inflation, 2017–21
Table 22: Japan consumer price index (absolute), 2017–21
Table 23: Japan exchange rate, 2017–21
LIST OF FIGURES
Figure 1: Japan pharmaceuticals market value: $ billion, 2016–21
Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Japan pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in Japan, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Japan, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Japan, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2021
Figure 10: Japan pharmaceuticals market share: % share, by value, 2021
Figure 1: Japan pharmaceuticals market value: $ billion, 2016–21
Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Japan pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in Japan, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Japan, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Japan, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2021
Figure 10: Japan pharmaceuticals market share: % share, by value, 2021
